NEW YORK (GenomeWeb News) – The National Cancer Institute has renewed a contract agreement with GeneArt, under which the company already has developed over 3,500 synthetic genes for around $3.5 million, the company said Friday.
 
GeneArt said it has agreed to develop another 200 genes for NCI’s Mammalian Gene Collection Program for an additional $1.9 million.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.